10 August 2023 1 Min Read
US FDA approves Johnson & Johnson’s blood cancer therapy
Talvey will be sold at a list price of $45,000 per month
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In